Live Breaking News & Updates on கிரீன் பேங்க் மூலதனம்

Stay updated with breaking news from கிரீன் பேங்க் மூலதனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DGAP-News: GreenBank Capital Inc.: GreenBank Capital to Acquire Significant Stake in Globally Important COVID-Killer


DGAP-News: GreenBank Capital Inc.: GreenBank Capital to Acquire Significant Stake in Globally Important COVID-Killer
vom 04.05.2021, 12:00 Uhr
Bild: pixabay.com
GreenBank Capital Inc.: GreenBank Capital to Acquire Significant Stake in Globally Important COVID-Killer
04.05.2021 / 12:00
GreenBank Capital to Acquire Significant Stake in Globally Important COVID-Killer
This news release is not for distribution or dissemination in the United States of America
TORONTO, ON / ACCESSWIRE / May 4, 2021 / GreenBank Capital Inc. (CSE:GBC)(OTC PINK:GRNBF)(FRA:2TL) ( GreenBank or the Company ) is exceptionally pleased to announce that it has reached agreement to acquire a significant stake in CodiKoat, the UK-based producer of a patent-pending destroyer of the COVID-19 virus ( Covid ) and any of its mutations, together with any other existing and novel viruses that could emerge in the future. ....

New York , United States , United Kingdom , City Of , Payam Nahavandi , Mark Wettreich , Raj Sharma , David Lonsdale , Reza Saberi , Matin Mohseni , University Of Cambridge , Merchant Bank , Greenbank Capital Inc , Canadian Securities Exchange , Distribution Services , Greenbank Capital , Bank Capital Inc , Acquire Significant Stake , Globally Important , Bank Capital , United Kingdom Based , Medical Imaging , Frankfurt Boerse , Investor Presentation , Corporate News , Regulatory Announcements ,

GreenBank Capital Inc.: GreenBank Capital to Acquire Significant Stake in Globally Important COVID-Killer


GreenBank Capital Inc.: GreenBank Capital to Acquire Significant Stake in Globally Important COVID-Killer
This news release is not for distribution or dissemination in the United States of America
TORONTO, ON / ACCESSWIRE / May 4, 2021 / GreenBank Capital Inc. (CSE:GBC)(OTC PINK:GRNBF)(FRA:2TL) ( GreenBank or the Company ) is exceptionally pleased to announce that it has reached agreement to acquire a significant stake in CodiKoat, the UK-based producer of a patent-pending destroyer of the COVID-19 virus ( Covid ) and any of its mutations, together with any other existing and novel viruses that could emerge in the future.
Any surface treated with CodiKoat products instantly becomes a Covid-destroying medium. From touchscreen terminals, to hospital surfaces and supermarket trolley handles, as well as masks and gloves, the CodiKoat application instantly destroys Covid and any other viruses on contact. ....

New York , United States , United Kingdom , City Of , Payam Nahavandi , Mark Wettreich , Raj Sharma , David Lonsdale , Reza Saberi , Matin Mohseni , University Of Cambridge , Merchant Bank , Greenbank Capital Inc , Canadian Securities Exchange , Greenbank Capital , United Kingdom Based , Medical Imaging , Frankfurt Boerse , Investor Presentation , Green Bank , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , ராஜ் ஷர்மா , டேவிட் லோன்ஸ்டேல் ,